ArticleOPEN ACCESS

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study (PLoS ONE (2019) 14:2 (e0212989) DOI: 10.1371/journal.pone.0212989)

PLoS ONE
DOI: 10.1371/journal.pone.0215491
4Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An incorrect version of S2 File was published in error. This article was republished on April 2, 2019 to correct for this error. Please download this article again to view the correct version.

Cite

CITATION STYLE

APA

Motoya, S., Watanabe, K., Ogata, H., Kanai, T., Matsui, T., Suzuki, Y., … Hibi, T. (2019, April 1). Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study (PLoS ONE (2019) 14:2 (e0212989) DOI: 10.1371/journal.pone.0212989). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0215491

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free